Abstract
Objective To investigate the association of visual impairment (VI) with brain structures in the UK Biobank Study.
Methods The UK Biobank Study is a large prospective study that recruited more than 500,000 participants aged 40-69 from 2006 to 2010 across the UK. Visual acuity (VA) of worse than 0.3 LogMAR units (Snellen 20/40) was defined as VI. Structural magnetic resonance imaging (MRI) data were obtained using a 3.0-T MRI imager. Volumetric measures of five global brain volumes (total brain volume, total grey matter, total white matter, cerebrospinal fluid (CSF), brain stem) and the volumes of seven specific brain region (thalamus, caudate nucleus, basal ganglia, pallidum, hippocampus, amygdala and nucleus accumbens) were included in the present analysis. Multivariable linear regression was used to investigate the association of VI with global and specific brain volumes.
Results A total of 8976 participants free of neurological disorders at baseline assessment were included for the present analysis. The prevalence of VI was 0.02% (n=181). After adjusting for a range of cofounding factors, VI was significantly associated with decreased volumes of the total brain (β = -0.12, 95% confidence interval (CI) -0.23 to 0.00, P = 0.049), thalamus (β = -0.16, 95% CI -0.18 to -0.04, P = 0.010), caudatenucleus (β = -0.14, 95% CI -0.27 to 0.00, P = 0.046), pallidum (β = -0.15, 95% CI-0.27 to -0.02, P = 0.028) and amygdala (β = -0.18, 95% CI -0.31 to -0.04, P = 0.012).
Interpretation We found that VI is associated with a decrease in total brain volumes and the volumes of specific brain regions implicated in neurodegenerative diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The present work was supported by the Fundamental Research Funds of the State Key Laboratory of Ophthalmology, Project of Investigation on Health Status of Employees in Financial Industry in Guangzhou, China (Z012014075), Science and Technology Program of Guangzhou, China (202002020049). Prof. Mingguang He receives support from the University of Melbourne at Research Accelerator Program and the CERA Foundation. The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian State Government. The sponsor or funding organization had no role in the design or conduct of this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Access to the UK Biobank data was granted after registration. The application ID for the present study was 62443. The UK Biobank has obtained Research Tissue Bank approval from its Research Ethics Committee recommended by the National Research Ethics Service (reference 11/NW/0382). Participants provided written informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All bona fide researchers could apply to UK Biobank resources for health-related research with benefit to public health. (see ukbiobank.ac.uk/register-apply). The application ID for the present study was 62443.
Abbreviations and Acronyms
- VI
- visual impairment
- VA
- visual acuity
- MRI
- magnetic resonance imaging
- CNS
- central nervous system
- AD
- Alzheimer’s disease
- PD
- Parkinson’s disease
- CSF
- cerebrospinal fluid
- BMI
- body mass index
- IOP
- intraocular pressure
- CH
- corneal hysteresis
- OCT
- optical coherence tomography
- SD
- standard deviation
- FDR
- false discovery rate
- PHQ
- Patient Health Questionnaire
- LogMAR
- logarithm of the minimum angle of resolution
- CI
- confidence intervals
